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Abstract 
Constraining the rise in costs continues to be a major focus of health care policy in high income countries. It is 
important for governments to understand what is driving the rise in health care expenditure and what the impact will be 
over the coming years. This paper aims to provide an alternative econometric model to ascertain the determinants of 
health expenditure. Data from the OECD and IMS data bases for 18 OECD countries between 1988 and 2012 is 
collected. The analysis is at the year and country level. This study applies three methods: (1) panel data models with 
country fixed effects; (2) a first difference model; (3) a Vector Error Correction Model to account for the long run and 
short run effects as well as the endogeneity of the explanatory variables. The empirical results suggest that the use of 
different econometric specifications has a significant impact on both establishing the determinants of health expenditure 
and their magnitudes. Based on results from the Vector Error Correction Model, the GDP is considered as the only 
driver for country level health care expenditure growth. A 1% increase in the GDP is associated with a 1.1% increase in 
the health care expenditure.  
Keywords: health expenditure, OECD countries, time-series, vector error correction model  
1. Introduction 
Controlling the rising costs of health care continues to be a major focus of health care policy internationally. In the UK 
for example, health expenditure (HE) growth is outstripping that of national income, and without increasing taxes or 
rearranging the way health care is provided this differential will place a lot of pressure on healthcare funding. 
Interestingly, there are substantial between-country differences in health care expenditure per capita, even amongst high 
income countries with generally healthy populations. For instance, in 2011, there were large disparities in per capita 
spend on healthcare across 18 OECD countries, varying from US$2,3551 per capita in Portugal, to more than double 
this, US$5,121 in Norway. Such international comparisons can be used to investigate, and hopefully explain, differences 
in HE and its progression over time. Typically this is done through econometric analysis of macroeconomic data.  
It is important for governments to understand what determine the rise in health care expenditure and what the impact 
will be over the coming years. In existing analyses of the drivers of national HE, the estimated relationship varies 
considerably. The primary differentiating issue is the model specification. This study aims to develop a modelling 
approach that could be used to establish the determinants of national HE for 18 high income countries.  
Section 2 discusses the research background of the determinants of HE. Section 3 describes the data. Section 4 outlines 
the three econometric methods for modelling the HE data. The results are presented in Section 5, followed by a 
discussion in Section 6 and conclusions in Section 7.  
 
                                                        
1 Analysis of OECD data from this study, in 2005 US$. 
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2. Literature Review 
Two streams of literature are reviewed: 1) the determinants of per capita HE and 2) the econometric approaches that 
have been used to model them. The review was focused on macro-level econometric models. 
2.1 Determinants of National Health Care Expenditure 
Drivers of HE can be separated into demographic and non-demographic factors (de la Maisonneuve & Oliveira Martins, 
2013). Demographic drivers relate to the age and health status of the population, whilst non-demographic drivers 
include income and other variables (e.g. price of health care, technology and characteristics of a health care system).  
2.1.1 Demographic Characteristics  
Demography was often included as a determinant of HE, usually measured by the share of the population of an elderly 
age group, e.g. over 65 years old, or by the average age of the population (de la Maisonneuve & Oliveira Martins, 2013). 
It could be expected that an aging population would cause an increase in per capita HE. However, a number of studies 
have assumed that proximity to death, rather than age, is the key demographic driver of HE. This theory is consistent 
with observed data that individual HE tends to increase exponentially as patients approach death (Breyer & Felder, 2006; 
Seshamani & Gray, 2004; Felder et al., 2000). The mortality rates rise with age, all else equal. At the same time, due to 
advances in medicine, life expectancy rising. A simplistic proxy like average age, or share of the population over 65, 
does not take into account the latter. This is why readily measurable demographic characteristics are rarely found to be 
statistically significant in regression models of per capita HE (Hitiris & Posnett, 1992; Di Matteo & Di Matteo 1998; 
Leu, 1986). 
2.1.2 Non-Demographic Characteristics: Income  
The income elasticity of health spending has been debated widely, and is still uncertain (Lago-Penas et al., 2013). 
Previous results suggested that the income elasticity estimate depends on the countries reviewed, the time period and 
the estimation method. Lago-Penas et al. (2013) highlighted evidence on both sides of the debate: in the past health care 
has been found to be both a “luxury” good with an income elasticity greater than one (Liu, et al., 2011; Mehrara, et al., 
2010; Parkin, et al., 1987; Leu, 1986; Newhouse, 1977), and a “necessity” with an income elasticity less than one 
(Baltagi & Moscone, 2010; Chakroun, 2009; Sen, 2005; Gerdtham et al., 1998; Gerdtham, 1992). The review also 
identified research suggesting that the income elasticity for national HE could be close to 1 (Gerdtham, 1992; Hitiris & 
Posnett, 1992). The author concluded that whilst the reviewed studies generally found the income elasticity to be 
positive, consensus is still not reached on whether health care is a necessity or a luxury good. 
In the same study, Lago-Penas and colleagues conducted their own analyses (Lago-Penas et al., 2013). They found the 
estimated short-run elasticity to be around 0.3, and the long-run elasticity to be 1.1, which is similar to the results of 
Gerdtham’s dynamic analysis that was published in 1992. 
Getzen in 2006 provided a comprehensive literature review that identified more than 40 empirical studies about the 
sources of variation in HE. Getzen (2006) found that as the unit of observation becomes larger (i.e. whether analysis is 
performed at the individual, the regional or national level), the correlation between HE and GDP increases in strength, 
i.e. an analysis at the person level finds HE to be inelastic with respect to income, while at country-level finds the 
opposite. This suggests that the income elasticity depends on the level of aggregation of data.  
A recent OECD report in 2013 about national HE projection used 0.8 as the income elasticity, with a value of 1 for a 
sensitivity analysis (de la Maisonneuve & Oliveira Martins, 2013). This figure was used on the basis of a literature 
review as well as a linear panel data regression model with country fixed effects and time trends.  
2.1.3 Other Non-Demographic Variables  
Various other non-demographic drivers of HE were discussed in the literature. The OECD report suggested that the 
relative price of health services, technological progress and underlying health policies and institutions are likely to be 
the key other non-demographic drivers for HE (de la Maisonneuve & Oliveira Martins, 2013). Given the lack of 
appropriate variables representing many non-demographic drivers, the OECD report left an unexplained “residual” 
factor in its model explaining HE growth. It has been noted that the residual effect is large, and accounts for more than 
50% of changes in HE (Medeiros & Schwierz, 2013).  
Prices in the health sector relative to the rest of the economy are clearly a driver of HE. If inflation in any sector is higher 
than that for the rest of the economy, then real expenditure in that sector increases, other things being equal. In health, as in 
other areas of the economy where labour costs feature as a large part of the whole and productivity growth is constrained 
by the face to face nature of many of the services delivered, this increase is predominantly driven by what’s known as the 
“Baumol effect” or “cost-disease” (Baumol, 1967). The relatively high cost increases in these sectors reflect the negative 
productivity differential and the equalisation of wages across the economy i.e. prices for health services will rise relative to 
other prices because wages in low productivity sectors must keep up with wages in the economy as a whole.  
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New technologies are being developed and launched all the time. One of the key categories of new technologies in 
health care is new pharmaceuticals and medical devices. Governments and other health care payers have traditionally 
seen new medicines as one of the sources for increasing cost, at least in the short term. This is either because the new 
drug or other technology improves the quality of health care, but is more expensive than the treatment it is replacing, or 
it provides treatment for a need that could previously not be met. It counters to most industries, where new technologies 
tend to reduce costs. The existence of new technologies, especially medicines, also has the effect of reinforcing patients’ 
expectations for care. On the other hand, new medicines and other technologies are also a source of productivity growth: 
better patient outcomes per pound spent. 
One would expect systematic characteristics of each country’s healthcare system to affect their HE. For instance the 
manner of service provision (e.g. the existence of a gatekeeper to the provision of secondary services) or the manner of 
health financing, provider payment mechanisms (e.g. whether the systems follow reimbursement, contract or integrated 
systems). In the latest publication of 2016 by de la Maisonneuve and colleagues, they explored the policies and 
institutional determinants of health spending in the OECD countries between 2000 and 2010 (de la Maisonneuve et al., 
2016). There are 20 health policies and institutional indicators included in their empirical analysis, from both the 
supply-side aspects (e.g. provider payment, provider competition) and the demand-side aspect (e.g. gatekeeping, 
cost-sharing). The results suggested that the estimate of the income elasticity of public health expenditures becomes 
larger than one when health policy and institutional indicators were included as the independent variables of modelling 
the public health expenditure. Those 20 indicators were dropped out when the fixed effects method applied, as they are 
all time-invariant. The fact that these attributes tend to be either fixed or at least sticky over time means one may control 
for them using fixed effects analysis.  
2.2 Econometric Methods  
Gerdtham & Jӧnsson (2000) performed an extensive literature review of the analysis of aggregate data on the 
determinants of HE in OECD countries. The analysis of macroeconomic HE has mostly been based on simple demand 
theory – namely calculating income elasticity of demand by regressing HE on gross domestic product (GDP). Early 
versions of these analyses were performed on cross-sectional data. Newhouse (1977) used 1971 data from 13 countries. 
He regressed GDP on HE and found that 92% of the variation in HE was explained by GDP. On this basis, he concluded 
firstly that other factors such as prices, demographics and quality had little effect on HE, and secondly that health is a 
luxury good2.  
Parkin et al. (1987) argued that Newhouse’s conclusions on income elasticity were based on microeconomic principles 
applied to macroeconomic data, causing aggregation problems. Parkin and colleagues also highlighted the likelihood of 
misspecification of the model, due to probably both omitted variable bias and inadequate functional form. Attempts to 
include more variables in the multivariate cross-section analysis were made by Gerdtham et al. (1992) and Leu (1986).  
The first attempts to refine the functional form of the model arrived with improvements in panel data methods. These 
enabled researchers to account for and test the presence of country specific, time invariant determinants of healthcare 
expenditure. The static panel data model allows for variable intercepts to represent country fixed effects as well as a time 
trend. It is established in the literature that in dealing with macro data from OECD countries, it is appropriate to take the 
fixed effects regression approach (Gerdtham & Jӧnsson, 2000) either with a time trend or without. A number of studies in 
the 1990s using panel data methods (Roberts, 1999; Gerdtham et al., 1998; Gerdtham et al., 1992; Hitiris & Posnett, 1992).  
Gerdtham (1992), accepting the likely dynamic nature of the determinants of HE, confronted issues of lags and the 
dynamic response of HE to changes in exogenous regressors. This dynamic analysis was furthered later in the 1990’s 
with the use of co-integration analysis. It became apparent that several of the variables used in previous panel data 
studies were non-stationary (e.g. HE and GDP), following major findings that applying OLS to non-stationary variables 
may lead to “spurious regressions” (Engle & Granger, 1987). Non-stationary variables are said to follow a “unit-root”, 
meaning that the level of variable 𝑦𝑡 at time 𝑡 depends on the all of the values of y that came before it, i.e. 
(𝑦0, … , 𝑦𝑡−1). 
Many macroeconomic variables including HE and GDP might be non-stationary at levels but stationary at first 
difference. In this case one can estimate the relevant coefficients by running a regression analysis in first differences. 
However, this process may result in a loss of information regarding the long-run relationships between variables, so 
while in some cases it is acceptable, it may not be the best course of action. This is particularly true if there exists a long 
run equilibrium relationship between variables and therefore an error correction mechanism involved in determining HE. 
If this mechanism exists and is omitted, then the use of first differences in a standard linear regression is a 
misspecification and is likely to result in biased estimates.  
                                                        
2 Coefficients for income elasticity varied from 1.13-1.31 (Newhouse, 1977). 
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When two or more variables are integrated of the same order it is possible that they follow a co-integrating relationship 
i.e. a linear combination of these non-stationary variables is itself stationary. Granger (1981) was able to show that an 
OLS regression on a set of co-integrated variables will still produce consistent estimates. It is possible to test for such 
integration using the residuals from an OLS regression, such as in the test employed by Engle & Granger (1987)3. 
Hansen & King (1996) performed individual country-by-country unit root and co-integration testing. Based on their 
results they could not (generally) reject the unit root hypothesis for HE or GDP. Nor could they reject the null 
hypothesis that HE and GDP are not co-integrated, which provides no support for the existence of equilibrium 
co-integrating relationships between HE and GDP. They then suggested that panel data estimations of HE and GDP 
relationships are spurious. Blomqvist & Carter (1997) performed individual country by country and panel data unit root 
tests and individual country-by-country co-integration tests. They reached the same results as Hansen & King (1996) 
concerning the unit-root hypothesis, but they rejected the no co-integration hypothesis. Roberts (1999) performed 
similar tests and found evidence of a co-integrating relationship between HE and GDP to be inconclusive. McCoskey & 
Selden (1998) presented unit root test results for time series on per capita national HE and GDP in the OECD. Their 
results rejected the unit root hypothesis.  
A recently published study in 2016 by Hauck & Zhang estimated the drivers of HE growth in 34 OECD countries 
between 1980 and 2012. The econometric model in this paper accounted for the heterogeneous effects of unobserved 
common factors on HE growth across countries. Furthermore, the method addressed model uncertainty that related to 
choice of regressors by Bayesian Model Averaging. The study found 16 significant drivers for HE growth, including the 
growth in GDP per head. The estimated elasticity of HE growth with respect to GDP per head is 0.77. A methodological 
limitation of this study is that the country-specific regressors are assumed to be stationary and exogenous. It does not 
allow for unit roots and other dynamic nature of the time series data. 
This study adds empirical evidence to the discussion about the determinants of national HE. First, it uses a recent and 
25 years’ panel data set, looking at similarly high income OECD countries. Second, it uses a wider range of variables 
than in other studies, looking for new and richer equilibrium relationships.  
3. Data 
Data used in the empirical analyses are collected annually, from 1988 to 2012, for 18 OECD countries: Australia, 
Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, New Zealand, 
Norway, Portugal, Spain, Sweden and the United Kingdom. The country selection is driven by data availability for key 
variables, i.e. GDP per head and HE per head. The statistics summary and data source are reported in Table 1. 
Table 1. Statistics summary and data source  
Variable names Mean SD Min Max Obs Source 
Total health spend a 62914.2 70250.0 3637.9 339130.6 450 OECD 
GDP b 693264.6 705385.3 55235.3 3009809.0 450 OECD 
Population c 24260 23932 3344 82534 450 OECD 
Log health spend per head d 7.8 0.4 6.7 8.6 450 Derived 
Log GDP per head e 10.2 0.2 9.5 11.0 450 Derived 
Share over 65 f 0.2 0.0 0.1 0.3 450 OECD 
Standardised mortality rate g 772.8 120.6 506.3 1115.0 450 OECD 
Global pharma spend h 417478.5 201395.5 161050.4 760694.3 450 IMS 
Relative health price i 1.0 0.1 0.4 1.6 425 k OECD 
Average wage j 37062.5 7327.9 14937.0 52838.0 425 l OECD 
a It refers to private and public HE in million (US$ at 2005 prices)  
b GDP in million (US$ at 2005 prices)  
c Population per 1000 
d Log of HE per head (US$ at 2005 prices)  
e Log of GDP per head (US$ at 2005 prices)  
f Proportion of population over 65 years old 
g Death rate per 100,000 of the population 
h Global spend on pharmaceuticals in million (US$ at 2005 prices)  
i Health and social value deflator divided by GDP deflator  
j Average annual wage per head (US$ at 2013 prices)  
k Information for Ireland is missing  
l Information for New Zealand is missing  
                                                        
3 Extensions of this test to panel data have been created by Johansen (1991) and McCoskey & Kao (1998). The 
Johansen fisher panel co-integration test has been applied to the empirical analysis of this study.   
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The selected variables in the empirical analysis followed the findings from the literature review in Section 2. HE is the 
key variable of interest. GDP is used as a proxy for income. The demographic characteristics of a country are measured 
by the proportion of the population aged above 65 years old and the standardised mortality rate. The standardised 
mortality rate could also be used as a measure of quality for health care. The relative health prices is measured by two 
variables, i.e. the national annual average wage per head, and the health and social value deflator adjusted by the GDP 
deflator. Technology is proxied by global pharmaceutical spend.  
The data set is complete for GDP per head and global pharmaceutical spend (n=450). There are missing values reported 
in other four variables, i.e. HE (n=446), proportion of population over 65 years old (n=423), standardised mortality rate 
(n=434) and relative health price (n=341). It is assumed that there is a linear relationship between the missing value and 
available data points within a country for each variable. All missing values based on this rule for the four variables are 
imputed. The econometric analysis of the best model in this study is based on the data set with imputation. Sensitivity 
analysis is also provided to check the robustness of the results, use data set without imputation.  
4. Econometric Methods 
In the econometric analysis, three separate techniques were applied. In the first model, a fixed effects method was used 
with error terms clustered at country level. However, this raised concerns about the stationarity of variables. In the 
second model, a first difference method was used with error terms clustered at country level. In the third model, a group 
of Vector Error Correction (VEC) models was implemented followed by the VEC residual portmanteau test. This 
approach addressed the key characteristics of the data, i.e. non-stationarity, endogeneity, serial correlation between 
error-terms, and the assumed long run equilibria between variables. The Pantula principle was applied for selection and 
to compare the performance between models. The performance of Vector Autoregression (VAR) on models that show no 
long term equilibrium has also been checked.  
4.1 Fixed Effects Model  
The first model uses a fixed effect method with error terms clustered at country level. The specification is reported by 
equation (1).  
𝑙𝑜𝑔 (
𝐻𝐸𝑖𝑡
𝑁𝑖𝑡
) = 𝑓𝑖 + 𝛼𝐷𝑒𝑚𝑜𝑖𝑡 + 𝛽𝑙𝑜𝑔 (
𝑃𝑖𝑡
𝑃𝑌𝑖
) + 𝛾𝑙𝑜𝑔𝑄𝑖𝑡 + 𝛿𝑙𝑜𝑔 (
𝑌𝑖𝑡
𝑁𝑖𝑡
) + 𝜖𝑙𝑜𝑔𝑇𝑒𝑐𝑕𝑡 + 𝜃𝑡 + 𝜀𝑖𝑡             (1) 
Where 
𝐻𝐸𝑖𝑡
𝑁𝑖𝑡
 refers to HE per head at country i and year t, which is derived from total 𝐻𝐸𝑖𝑡 and population 𝑁𝑖𝑡; 𝑓𝑖 
refers to country fixed-effects, allowing HE to vary across countries; the demographic effect 𝐷𝑒𝑚𝑜𝑖𝑡 is captured by the 
share of the population over 65 years old; the relative price of health services 
𝑃𝑖𝑡
𝑃𝑌𝑖
 is calculated as the health and social 
care value deflator 𝑃𝑖𝑡 divided by the whole economy value deflator 𝑃𝑌𝑖 4; the quality of health care 𝑄𝑖𝑡 is proxied by 
the standardised mortality rate; 
𝑌𝑖𝑡
𝑁𝑖𝑡
 is GDP per capita for country i at year t; technology is proxied by total global 
expenditure on pharmaceuticals 𝑇𝑒𝑐𝑕𝑡 ; t is a time trend; and 𝜀𝑖𝑡 is a random error term.  
There are two assumptions for equation (1). First, all independent variables are weakly exogenous. Second, the error 
terms are assumed to be independent and identically distributed (i.i.d).  
Wooldridge test for residual autocorrelation in panel data was applied after each regression analysis (Drukker, 2003; 
Wooldridge, 2002).  
4.2 First-Difference Model  
Assuming error terms in equation (1) are independent and identically distributed is a strong assumption for modelling 
time series data, as non-stationarity is a commonly observed characteristic for time series data. Non-stationary error 
terms violate the assumptions required for OLS to produce consistent estimates which can lead to meaningless results
5
. 
Many macroeconomic variables including (typically) HE and GDP are non-stationary but integrated of order one – 
                                                        
4 The OECD average wage by country was used as an alternative proxy. 
5 Granger (1981) showed that an OLS regression on a set of co-integrated variables will still produce consistent 
estimates. One is able to test for cointegration using the residuals from an OLS regression, such as in the test employed 
by Engle & Granger (1987). 
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meaning that if one takes first differences (subtract the previous value of each variable from the current value) then the 
variable becomes stationary. A panel regression is performed with all variables take their first differences. The 
specification of the first difference model is reported in equation (2).  
∆𝑙𝑜𝑔 (
𝐻𝐸𝑖𝑡
𝑁𝑖𝑡
) = 𝛼∆𝐷𝑒𝑚𝑜𝑖𝑡 + 𝛽∆𝑙𝑜𝑔 (
𝑃𝑖𝑡
𝑃𝑌𝑖
) + 𝛾∆𝑙𝑜𝑔𝑄𝑖𝑡 + 𝛿∆𝑙𝑜𝑔 (
𝑌𝑖𝑡
𝑁𝑖𝑡
) + 𝜖∆𝑙𝑜𝑔𝑇𝑒𝑐𝑕𝑡 + 𝜃𝑡 + 𝜀𝑖𝑡           (2) 
4.3 Vector Error Correction Model (VECM)  
4.3.1 Issues with Specification in Equation (2) 
There are two issues with the specification in equation (2). First, it contains the strong assumption that all of the 
independent variables included are weakly exogenous i.e. that there is no correlation between the variables and the error 
terms. But one may argue that, for instance, the proportion of people at age above 65 years is an endogenous variable in 
modelling HE at country level. A higher proportion of people age above 65 years old in a country might lead to more 
HE in that country, while a large spend on health might have a positive impact on the overall health of a country and 
therefore contribute to an increase in the proportion of people aged over 65.  
Second, the equation (2) assumes that there is no serial correlation between error terms. Again, this is a strong 
assumption. The error terms in modelling HE include a number of unobserved variables. With 25 years’ panel data, the 
errors might show autocorrelations because of the unobserved variable(s). Therefore, an autocorrelation test should be 
applied to check the serial correlation of residuals after all regressions.  
Furthermore, model 2 uses only short run data variation to analyse the drivers of HE. Any long run information 
contained in the data is taken out by the first difference. If there is long term equilibrium between variables, but the 
effect is omitted from the model, then the use of first differences in a standard linear regression is a misspecification and 
is likely to result in biased estimates. 
4.3.2 Specification of the VECM  
In order to account for the three issues with model 2, the VECM is considered. This model is a representation of the 
VAR model that is appropriate to use if there is at least one long-run equilibrium relationship between the variables 
present. Both models assume that the variables included are endogenous. For all VECM specifications a residual 
autocorrelation test was applied. The general specification of the VECM is presented by equation (3) (Engle & Granger, 
1987). For an accessible introduction to empirical model building in economics see Granger (1999).  
∆𝑦𝑖𝑡 = ∑ Γ𝑖𝑘∆𝑦𝑖𝑡−𝑘
𝑝
𝑘=1
+ 𝛼(𝑢𝑖𝑡−1) + 𝛾 + 𝜃𝑡 + 𝜀𝑖𝑡                                                          (3) 
     𝜀𝑖𝑡~𝑁(0, Σ𝑢) 
This model takes into account both the short run dynamics among the variables collected in the 6 x 1 vector 𝑦𝑖𝑡 =
[
𝐻𝐸𝑖𝑡
𝑁𝑖𝑡
, 𝐷𝑒𝑚𝑜𝑖𝑡 ,
𝑃𝑖𝑡
𝑃𝑌𝑖
, 𝑄𝑖𝑡,
𝑌𝑖𝑡
𝑁𝑖𝑡
, 𝑇𝑒𝑐𝑕𝑡]′ , and the long-run structure presented by the vector of co-integrating residuals 𝑢𝑖𝑡−1:  
𝛽𝑦𝑖𝑡−1 + 𝜇 + 𝜌𝑡 =  𝑢𝑖𝑡−1                                                                             (4) 
Γ𝑖𝑘 is a matrix of autoregression coefficients, 𝑝 is the number of lag intervals, 𝛼 is a matrix of coefficients adjusting 
for short run dynamics to the long run equation, 𝛾 is a vector of intercept terms and 𝑡 is the time trend, 𝛽 is the 
matrix of coefficients for long run equilibrium, 𝜇 is a vector of intercept terms for long run equilibrium.  
There are five specifications of the model represented in equation (3) with different assumptions on the inclusion of an 
intercept term or time trend in the cointegration equation (CE) and the short run dynamics (or VAR). The first 
specification of deterministic trend assumes that there is no intercept or trend in the CE (𝜇 = 0 and 𝜌 = 0) and the VAR 
(𝛾 = 0 and 𝜃 = 0). The second assumes that there is no trend in the CE or the VAR, but there is an intercept in the CE. 
The third assumes that there is an intercept in the CE and both an intercept and a trend in the VAR. The fourth assumes 
that there is a trend and intercept in the CE, and an intercept but no trend in the VAR. The fifth specification assumes 
that there is an intercept and quadratic trend in the CE, and a linear trend in the VAR. Each of these specifications is 
performed for each combination of variables.  
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4.3.3 VECM Process 
It takes three steps to specify a VECM. First, one needs to check whether any long-run equilibrium exist, using the 
Johansen Fisher Panel Co-integration test. Then, if the test suggests that at least one equilibrium does exist, the task is to 
choose the number of lag intervals (k). Allowing k to equal to 1, 2 or 3 have been experimented in this study. Finally, 
five specifications with different assumptions of intercept and trends in the CE and VAR that described in the previous 
section are implemented.  
15 econometric models (3 choices of lag intervals x 5 structures of deterministic trend) are tested, one for each choice of 
variables. In total, there are 6 sets of variables and therefore 90 econometric specifications are experimented. The 6 sets 
of variables are the same as those in the first difference models. For specifications that show at least one long run 
equilibrium relationship, the autocorrelation test is applied to check for serial correlation in the residuals. For 
specifications that suggest no long run equilibrium, the VAR model (a model that only accounts for the short run 
dynamics) is applied, followed by an autocorrelation test.  
4.3.4 Comparing the Performance between Models 
The Pantula principle is applied to compare the performance between models. The comparisons of performance are only 
made between models where the residual portmanteau test suggests no autocorrelation for up to eight lags. The key 
statistics that are compared include the specification of the deterministic trend, the number of co-integrating 
relationships, the number of insignificant coefficients, the log likelihood statistics, the AIC statistics, the Schwarz 
Criterion statistics and the results from autocorrelation tests.  
4.3.5 Sensitivity Analysis 
The best model in this study, i.e. VECM, is applied in the sensitivity analysis by applying the data set with no imputed 
values.  
The programmes used for data analysis and modelling were Eviews 8 and STATA/MP 13.1. 
5. Results  
5.1 Unit Root Tests 
The results from Augmented Dickey–Fuller (ADF) Fisher unit root tests are reported in Table 2. The results suggest that 
all variables are non-stationary in levels. All variables are stationary at first difference in levels. Apart from the 
proportion of population aged above 65, all variables are stationary at first difference of logs. 
  
Applied Economics and Finance                                          Vol. 4, No. 6; 2017 
8 
 
Table 2. ADF Fisher unit root test 
Variables  ADF Fisher Chi-square  Probability  
In level 
Health spend per head 7.54 1.00 
GDP per head 10.19 1.00 
Share over 65 42.58 0.21 
Standardised mortality rate 10.28 1.00 
Global pharma spend 0.09 1.00 
Relative health price  45.38 0.09 
Average wage 44.24 0.11 
In log 
Health spend per head 22.38 0.96 
GDP per head 13.82 1.00 
Share over 65 54.67 0.02 
Standardised mortality rate 4.46 1.00 
Global pharma spend 15.49 1.00 
Relative health price  70.80 0.00 
Average wage 59.83 0.00 
In first difference 
Health spend per head 176.36 0.00 
GDP per head 187.80 0.00 
Share over 65 57.00 0.01 
Standardised mortality rate 407.76 0.00 
Global pharma spend 122.54 0.00 
Relative health price  140.34 0.00 
Average wage 149.05 0.00 
In first difference of log 
Health spend per head 147.46 0.00 
GDP per head 179.22 0.00 
Share over 65 48.44 0.08 
Standardised mortality rate 384.22 0.00 
Global pharma spend 205.17 0.00 
Relative health price  162.85 0.00 
Average wage 176.96 0.00 
a Individual intercept are included in the unit root test equation.  
b Schwarz Information Criterion is used to automatically select the lag length in the unit root test.  
c Probability at 5% level is used as the threshold for accepting/rejecting the unit root null hypothesis.  
 
5.2 Regression Results 
In general, the results show that the specification of the model has significant impact on the results.  
Results from six fixed effects regressions are reported between column 1 and column 6 in Table 3. The log of GDP per 
head is used to represent national income. Results from the 6 models suggest that the estimated value of income 
elasticity fluctuates between 0.74 and 0.87, all of which are statistically significant at the 5% level. The demographic 
characteristics are proxied by the proportion of the population aged above 65; this is not significant at the 10% level in 
explaining HE in any models. Quality of health care is measured by the log of mortality rate. Results in columns 3-6 
suggest that the effect is not statistically significant at the 10% level. In column 5, the impact of relative health care 
price is found not to be statistically significant in explaining the HE. As an alternative measure of health price, the effect 
of average wage is also found not to be significant in column 6. Global pharmaceutical spend is used to measure health 
care technology. Results in column 5 suggest that a 1% increase in the global pharmaceutical spends is associated with a 
0.17% increase in HE. The effect is statistically significant at the 5% level. The effect is also reported as statistically 
significant at the 5% level in column 6 with a magnitude of 0.21%.  
Wooldridge test for autocorrelation in panel data strongly rejects the null hypothesis of no serial correlation for all 6 
models. The results are reported in the last row of Table 3.  
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Table 3. Fixed effects method  
Variables Column 1  
(t) 
Column 2 
(t) 
Column 3  
(t) 
Column 4  
(t) 
Column 5  
(t) 
Column 6  
(t) 
log GDP 0.8683** 
(14.62) 
0.8732** 
(12.89) 
0.8707** 
(14.73) 
0.8743** 
(12.92) 
0.8131** 
(9.84) 
0.7386** 
(9.13) 
Share over 65  0.1643 
(0.19) 
 0.1219 
(0.15) 
-0.2038 
(-0.36) 
0.8490 
(1.02) 
log mortality rate    -0.2226 
(-1.25) 
-0.2213 
(-1.26) 
-0.2427 
(-0.98) 
-0.1805 
(-1.04) 
log relative health price      0.2102 
(1.67) 
 
log wage       0.3630 
(1.69) 
log pharm spend     0.1742** 
(2.93) 
0.2051** 
(2.95) 
Year trend  0.0177** 
(10.10) 
0.0174** 
(8.38) 
0.0140** 
(4.21) 
0.0138** 
(3.80) 
0.0001 
(0.01) 
-0.0026  
(-0.34) 
Constant  -36.5808**   
(-11.69) 
-36.0630** 
(-10.18) 
-27.6667** 
(-3.70) 
-27.3350** 
(-3.46) 
-1.2511 
(-0.08) 
0.0799  
(0.01) 
Number of obs 450 450 450 450 425 425 
R2 0.8749   0.8773 0.8788   0.8805 0.8756 0.8849 
Prob > F a 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
** p<0.05; * p<0.1  
a Wooldridge test for autocorrelation in panel data with null hypothesis of no first-order autocorrelation. 
 
Columns 1-6 in Table 4 report results from the first-difference models. The estimated elasticity of HE with respect to 
income (0.33-0.44) is much lower than in the fixed effects models. The proportion of the population aged above 65 has 
a positive effect on HE in all models and is statistically significant at the 5% level in three models (reported in columns 
2, 4 and 5). Mortality rate is not significant in explaining HE in any of these models. In column 5, the impact of relative 
health care price is found to be statistically significant in explaining the HE. As an alternative measure of health price, 
the effect of average wage is also found to be significant in column 6. Estimates for the impact of technology and 
relative prices on HE that are reported in columns 5 and 6 suggest positive and significant effects at the 5% level.  
Table 4. First-difference method  
Variables Column 1  
(t) 
Column 2  
(t) 
Column 3  
(t) 
Column 4  
(t) 
Column 5  
(t) 
Column 6  
(t) 
D(log GDP) 0.4009** 
(4.84) 
0.3894** 
(4.82) 
0.4014** 
(4.85) 
0.3899** 
(4.84) 
0.4442**   
(5.80) 
0.3319** 
(5.02) 
D(Share over 65)  0.0357** 
(3.09) 
 0.0362**  
(3.03) 
0.0335** 
(2.57) 
0.0302 
(1.63) 
D(log mortality rate)    0.0282 
(0.60) 
0.0402 
(0.85) 
0.0061 
(0.12) 
0.0241 
(0.46) 
D(log relative health price)      0.2268** 
(3.48) 
 
D(log wage)       0.5099** 
(5.48) 
D(log pharm spend)     0.1446** 
(4.15) 
0.1440** 
(4.15) 
Year trend  -0.0005* 
(-1.81) 
-0.0003 
(-1.03) 
-0.0005  
(-1.73) 
-0.0003 
(-0.94) 
-0.0000 
(-0.08) 
-3.72e-06 
(-0.01) 
Constant  1.0576* 
(1.85) 
0.5562 
(0.93) 
1.0348* 
(1.78) 
0.51625 
(0.84) 
-0.0095 
(-0.02) 
-0.0425  
(-0.06) 
Number of obs 432 432 432 432 408 408 
R2 0.1125 0.1273 0.1129 0.1280 0.1875 0.2299 
** p<0.05; * p<0.1  
 
90 different specifications of the VECM are experimented, of which two show at least one long run equilibrium 
between variables, and no residual autocorrelation up to lag 8 with a 10% significance level. The first of these VECMs 
includes two variables: log GDP per head and log health spend per head. The second includes three variables: log GDP 
per head, log health spend per head and log mortality rate. Both models contain two lag intervals for the short run 
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dynamics (k=2) with a trend and intercept in the co-integrating equation and an intercept but no trend in the VAR. The 
key statistics about the performance of the two models are reported in Table 5. The results from the VECM residual 
portmanteau tests of the two models are reported in Appendices A and B.  
Table 5. Key statistics for two VECM 
Key statistics  VECM 1 VECM 2 
Number of lag interval  2 2 
Deterministic trend  A trend and intercept in 
the CE and an intercept 
but no trend in the VAR 
A trend and intercept in 
the CE and an intercept 
but no trend in the VAR 
Co-integration rank 1 2 
Number of insignificant coefficients   4 out of 12  15 out of 27 
Log likelihood  1668.88 2584.34 
AIC -8.35 -12.88 
Schwarz Criterion  -8.20 -12.52 
No residual autocorrelations up to lag (p<0.05) 21 8 
No residual autocorrelations up to lag (p<0.1)  18 8 
 
Applying the Pantula principle to compare the performances between two models, the first model (with log GDP per 
head and log health spends only) might suggest a better performance than the second (with log GDP head, log health 
spend and log mortality rate). The first model reports a smaller number of co-integrating relationships, a smaller 
proportion of insignificant variables in the VAR and a larger number of lags with no-serial correlation in residuals than 
the second model. The second model shows a higher log likelihood statistic and lower AIC and Schwarz Criterion 
statistics. This is expected as the second model includes more variables than the first model.    
Results from the best VECM are reported in Table 6. The magnitude of the effect of the time trend variable is rather 
small (8.49e-05) and not statistically significant at the 10% level. To increase the efficiency of the estimates, restrictions 
to time trend are imposed with a coefficient of zero. Results from the best model with this restriction are reported in 
Table 7. 
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Table 6. Best model without coefficients restrictions 
Cointegration equation  Cointegration equation 1  
LnHE (-1) 1.00  
LnGDP (-1) -1.09 
(0.13) 
[-8.35] 
 
Trend  8.49E-05 
(0.00) 
[0.37]  
 
Intercept 3.38  
Error correction  D(lnHE) D(lnGDP) 
Cointegration equation 1  -0.06 
(0.01) 
[-4.53] 
-0.02 
(0.01) 
[-1.70] 
D(lnHE(-1)) 0.12 
(0.05) 
[2.49] 
-0.04 
(0.04) 
[-0.87] 
D(lnHE(-2)) -0.03 
(0.05) 
[-0.55] 
0.09 
(0.04) 
[2.09] 
D(lnGDP(-1)) 0.14 
(0.06) 
[2.33] 
0.25 
(0.05) 
[4.66] 
D(lnGDP(-2)) 0.33 0.01 
 (0.06) (0.05) 
 [5.39] [0.24] 
Intercept  0.02 
(0.00) 
[7.44] 
0.01 
(0.00) 
[4.80] 
R-squared  0.23  0.09 
Adj. R-squared  0.22  0.08 
Sum sq. resids  0.41  0.31 
S.E. equation  0.03  0.03 
F-statistic  23.67  7.66 
Log likelihood  800.26  852.21 
IC -4.01 -4.27 
Schwarz SC -3.95 -4.21 
Mean dependent  0.03  0.02 
S.D. dependent  0.04  0.03 
Determinant resid 
covariance (dof adj.)  7.72E-07 
 
Determinant resid 
covariance  7.49E-07 
 
Log likelihood  1668.88  
AIC -8.35  
Schwarz criterion -8.20  
a Standard errors in ( ) & t-statistics in [ ]  
b Sample adjusted for a period between 1991 and 2012.   
c There are 396 observations included after adjustments.  
 
The results in Table 7 suggest that there is a long-run equilibrium between HE per head and GDP per head. The 
relationship is statistically significant at the 5% level. The income elasticity estimated in this long-run equilibrium 
model is 1.10. This implies that a 1% increase in GDP per head leads to HE per head increasing by 1.10% in the long 
run.  
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Table 7. Best model with coefficients restrictions 
Cointegration equation  Cointegration equation 1  
LnHE (-1) 1.00  
LnGDP (-1) -1.10 
(0.13) 
[-8.45] 
 
Intercept 3.46  
Error correction  D(lnHE) D(lnGDP) 
Cointegration equation 1  -0.06 
(0.01) 
[-4.52] 
-0.02 
(0.01) 
[-1.70] 
D(lnHE(-1)) 0.12 
(0.05) 
[2.48] 
-0.04 
(0.04) 
[-0.88] 
D(lnHE(-2)) -0.03 
(0.05) 
[-0.58] 
0.09 
(0.04) 
[2.08] 
D(lnGDP(-1)) 0.14 
(0.06) 
[2.33] 
0.25 
(0.05) 
[4.66] 
D(lnGDP(-2)) 0.34 0.01 
 0.06 0.05 
 [5.39] [0.25] 
Intercept  0.02 
(0.00) 
[7.45] 
0.01 
(0.00) 
[4.80] 
R-squared  0.23  0.09 
Adj. R-squared  0.22  0.08 
Sum sq. resids  0.41  0.31 
S.E. equation  0.03  0.03 
F-statistic  23.63  7.65 
Log likelihood  800.19  852.20 
IC -4.01 -4.27 
Schwarz SC -3.95 -4.21 
Mean dependent  0.03  0.02 
S.D. dependent  0.04  0.03 
Determinant resid 
covariance (dof adj.)  7.73E-07 
 
Determinant resid 
covariance  7.49E-07 
 
Log likelihood  1668.81  
AIC -8.35  
Schwarz criterion -8.20  
a Standard errors in ( ) & t-statistics in [ ]  
b Sample adjusted for a period between 1991 and 2012.  
c There are 396 observations included after adjustments.  
 
In the short run equation of HE, the coefficient for the co-integrating equation is negative and statistically significant at 
the 5% level. This implies that if there is a positive departure from the long run equilibrium, then HE will fall in order to 
return to the equilibrium level. However, GDP does not respond to any departure from the long run equilibrium between 
GDP and HE. This is reported by the statistically insignificant coefficient of the cointegration equation in the short run 
equation of GDP.  
In the short run, both GDP and HE respond to the lag of GDP and the lag of HE positively. HE per head responds to its 
own one year lag, one year lag of GDP per head and two year lag of GDP per head, significantly at the 5% level. GDP 
per head responds to its own one year lag and two year lag of HE per head significantly at the 5% level. 
For the specifications that suggest there is no long-run equilibrium, the VAR model is applied and followed by an 
autocorrelation test. The results suggest that there is no VAR specification that results in no autocorrelation up to 8 lags. 
For these specifications there is serial correlation in the residuals, implying that there are dynamic relationships the 
VAR cannot account for. To apply the VAR model to the data set would therefore likely lead to misspecification.  
There was no imputation required for GDP per head data. There were four missing observations reported in the HE data 
in 2012. A sensitivity analysis was conducted with VECM on a data set without imputation by dropping year 2012. The 
results suggest that the elasticity of income in the long run is statistically significant at the 5% level with a coefficient of 
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1.06. This is similar to the results in Table 7, i.e. 1.10. The coefficients of short run effects are also similar to the results 
in Table 7. An alternative method for inputting missing data is the Multiple Imputation technique (Hauck & Zhang, 
2016). One might not expect the different methods to have a large impact on the results as this is only relevant for 4 
observations.   
6. Discussion 
The three separate analyses performed in this study gave rise to rather different results for the magnitude of the national 
income elasticity of demand for health care expenditure.  
In a regression of levels with country fixed effects the results suggest that the income elasticity is less than one, with a 
high R2 term, but few statistically significant variables other than GDP. From this result one might conclude, as did in 
Newhouse (1977), that income is the foremost driver of HE. However, this first regression analysis should be treated 
with cautious, as in dealing with time series data there is always a risk that variables are non-stationary. Performing 
OLS regression on non-stationary variables can lead to spurious inferences and should be avoided.  
Having found through ADF tests that many of the variables used in this study are non-stationary and in fact appear to 
follow a unit root. The first difference is calculated for all variable – as time series data that follows a unit root might 
show “difference stationary”. The results of this set of regressions have a slightly different interpretation, due to the 
short-term information that is used. The income elasticity estimate here is much lower than in the standard panel 
regression because it denotes only the instant reaction of HE to changes in GDP. The estimated coefficients are 
therefore lower in the first difference regression, as well as the explanatory power of the model, implying that HE is not 
as responsive to changes in GDP instantaneously as it is in the long run.  
Using the VECM a long-run dynamic equilibrium relationship between GDP and HE was found. The results suggest 
that the long run elasticity of income is over, but close to 1. They also suggest that if there is a positive departure from 
the long run equilibrium, HE will, relatively slowly, fall in order to return to the equilibrium level. However, GDP does 
not respond to any departure from the long run equilibrium between GDP and HE. 
These results support other dynamic equilibrium models presented in Section 2 of the literature review as well as the 
results from model 2. There is a low, but statistically significant short run response to changes in the GDP. This short 
run elasticity is much lower than that found in the first difference model, at 0.14 rather than around 0.40. 
There are some limitations with the analysis, particularly concerning the data quality. Firstly, the log of relative health 
price reports large number of missing values (109/450 observations missing). The VECM can only be run on a fully 
balanced panel and therefore missing data need to be imputed: a linear assumption was applied to the data. Secondly, it 
is questionable that whether the variables selected in this study are good proxies. This is a common limitation of 
statistical analysis on macroeconomic health data. Thirdly, one might hypothesise that recent austerity measures, widely 
applied in high income countries since around 2008 would change the long run relationship between HE and its 
determinants. Unfortunately the lack of availability of very recent data makes the analysis of any hypothesised 
structural break due to recent austerity measures difficult. Many high income countries, especially the UK, have been 
attempting to reduce the proportion of their GDP spent on health. If they are successful, one would expect a change in 
the relationship between GDP and HE. However, given that the data are only available to 2012, there is no enough 
recent observations to explore this question. Finally, the analyses with the VECM pooled data from 18 countries. The 
pooled mean group estimation has been experimented which allows the short run coefficients and error variances to 
differ across countries. However, the reliability of the results is constrained by the short time period in the data, i.e. 25 
years. There is a trade-off which needs to be made between choosing a model that takes into account the heterogeneity 
between countries and a model that uses pooled data but produces more efficient estimates. It should be noted that 
Hauck & Zhang (2016) explored an econometric model that allows for unobserved heterogeneity in the effects of 
common shocks in modelling HE growth in 34 OECD countries.  
7. Conclusion 
This study provides empirical evidence about the determinants of national HE in high income countries. The results 
from the Vector Error Correction model suggest that the key driver of HE at national level is GDP, with a 1% increase in 
GDP per head associated with a 1.10% increase in HE per head. The empirical results also show that the use of different 
econometric specifications has a significant impact on both establishing the determinants of HE and their magnitudes. A 
key contribution of this study is to account for the dynamic nature of the macro level data while exploring the 
determinants of the national HE. Future methodological research might consider exploring methods that address both 
the dynamic nature of the macro level time series data as well as cross-country heterogeneity.  
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Appendix A: VEC residual portmanteau tests for autocorrelations in VECM 1 
Lags Q-Stat Prob. Adj Q-Stat Prob. Df 
1 0.560139 NA* 0.561557 NA* NA* 
2 1.513069 NA* 1.519324 NA* NA* 
3 8.995525 0.2530 9.058899 0.2485 7 
4 16.74397 0.1157 16.88641 0.1113 11 
5 20.94269 0.1387 21.13882 0.1325 15 
6 22.48464 0.2608 22.70450 0.2506 19 
7 24.17165 0.3944 24.42186 0.3808 23 
8 26.23046 0.5058 26.52312 0.4897 27 
9 35.64412 0.2590 36.15570 0.2403 31 
10 42.21125 0.1874 42.89296 0.1688 35 
11 45.74577 0.2124 46.52848 0.1901 39 
12 47.84562 0.2825 48.69394 0.2546 43 
13 51.02558 0.3184 51.98184 0.2860 47 
14 55.97575 0.2935 57.11343 0.2584 51 
15 60.31003 0.2898 61.61835 0.2513 55 
16 71.42972 0.1286 73.20623 0.1010 59 
17 74.92969 0.1444 76.86319 0.1126 63 
18 82.04618 0.1020 84.31857 0.0749 67 
19 88.22841 0.0811 90.81237 0.0566 71 
20 94.76888 0.0613 97.70074 0.0403 75 
21 97.13941 0.0811 100.2040 0.0539 79 
 
Appendix B: VEC Residual portmanteau tests for autocorrelations in VECM 2 
Lags Q-Stat Prob. Adj Q-Stat Prob. Df 
1 0.553394 NA* 0.554795 NA* NA* 
2 2.971187 NA* 2.984861 NA* NA* 
3 17.73194 0.2193 17.85829 0.2133 14 
4 27.21503 0.2469 27.43815 0.2378 23 
5 34.09356 0.3672 34.40464 0.3533 32 
6 46.52221 0.2555 47.02450 0.2394 41 
7 60.98906 0.1372 61.75168 0.1231 50 
8 65.64742 0.2574 66.50609 0.2344 59 
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